Sort
11,323 grants matching “glioblastoma”
Biochemical and cell biological mechanisms of signal transduction through the Hedgehog pathway
$674,414Rajat Rohatgi · Stanford University · R35 · FY2020 · GM
The Role of TIMPs in Cell Growth, Tumor Progression and Metastasis
$674,309William Stetler-Stevenson · Division Of Clinical Sciences - Nci · ZIA · FY2021 · CA
Enhancing cell therapy for brain tumors
$674,256Catherine Mary Bollard · Children'S Research Institute · U01 · FY2018 · CA
Mechanisms of non-classical multidrug resistance in cancer
$673,907Michael Gottesman · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Signal Transduction by Tyrosine Phosphorylation
$673,847Tony R. Hunter · Salk Institute For Biological Studies · R01 · FY2012 · CA
Synthetic lethalities to cell cycle disruption in glioma
$673,491Rameen Beroukhim · Dana-Farber Cancer Inst · R01 · FY2025 · CA
Targeting T cell dysfunction in glioblastoma: A proof-of-concept Phase 0/I trial of anti-TIGIT antibody AB154 in combination with anti-PD1 antibody AB122
$673,408Antonio M Omuro · Yale University · R01 · FY2023 · CA
Imaging and Targeted Auger Radiotherapy of High-Grade Glioma
$672,854Joel Richard Garbow · Washington University · R01 · FY2022 · EB
Understanding the cellular and functional changes in the immune tumor microenvironment of glioblastoma during progression and treatments.
$672,634Alain Charest · Beth Israel Deaconess Medical Center · R01 · FY2023 · CA
Imaging and Targeted Auger Radiotherapy of High-Grade Glioma
$672,460Joel Richard Garbow · Washington University · R01 · FY2023 · EB
Integrated ligand and target discovery by chemical proteomics for glioblastoma treatment.
$671,855Paul S Mischel · Stanford University · R01 · FY2022 · CA
STAT3, G6PD and TrxR as underlying mechanisms for antitumor responses to hirsutinolides
$671,829James K Turkson · University Of Hawaii At Manoa · R01 · FY2017 · CA
The impact of interstitial fluid flow on CAR T cell trafficking, distribution, and efficacy
$671,774Jennifer M Munson · Virginia Polytechnic Inst And St Univ · R01 · FY2022 · NS
Myeloid Recruitments and their Role in Brain Tumors
$671,763Dolores Hambardzumyan · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · NS
Molecular Mechanisms and Therapeutic Approaches to Malignant Gliomas
$671,581Inder Mohan Verma · Salk Institute For Biological Studies · R01 · FY2016 · CA
Molecular Mechanisms and Therapeutic Approaches to Malignant Gliomas
$671,581Tony R. Hunter · Salk Institute For Biological Studies · R01 · FY2018 · CA
Molecular Mechanisms and Therapeutic Approaches to Malignant Gliomas
$671,581Inder Mohan Verma · Salk Institute For Biological Studies · R01 · FY2017 · CA
Quantitative Non-Contrast Perfusion using Arterial Spin Labeling for Assessment of Cancer Therapy Response
$671,184Ananth J Madhuranthakam · Ut Southwestern Medical Center · U01 · FY2017 · CA
Brain-Restricted Kinase Inhibition with Binary Pharmacology
$671,177William A Weiss · University Of California, San Francisco · R01 · FY2024 · CA
Quantitative MRSI to predict early response to SAHA therapy in new GBM management
$671,166Hyunsuk Shim · Emory University · U01 · FY2013 · CA
Steady states and cellular transitions associated with carcinogenesis and tumorprogression
$670,711James R. Heath · Institute For Systems Biology · U01 · FY2021 · CA
Targeting platinum(IV) prodrug to GBM tumors using a brevican-binding peptide
$670,662Choi-Fong Cho · Brigham And Women'S Hospital · R01 · FY2025 · CA
Steady states and cellular transitions associated with carcinogenesis and tumorprogression
$670,576James R. Heath · Institute For Systems Biology · U01 · FY2020 · CA
Inverse Mapping of Spatial-Temporal Molecular Heterogeneity from Imaging Phenotype
$670,480Jing Li · Georgia Tech Research Corporation · · FY2020 · MPS
Imaging signatures of genetic mutations in glioblastoma using machine learning
$670,422Christos Davatzikos · University Of Pennsylvania · R01 · FY2020 · NS